Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole-based endometrial preparation for frozen blastocyst transfer in women with PCOS
IRCT20080831001141N38Phase 3Completed
- Sponsor
- Royan Institute
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of letrozole, human chorionic gonadotropin, gonadotropin-releasing hormone agonist, estradiol valerate and progesterone in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by Royan Institute. Primary endpoint: Clinical pregnancy rate. Started Sep 2021; status: completed.
02
Drugs
letrozolehuman chorionic gonadotropingonadotropin-releasing hormone agonistestradiol valerateprogesterone
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on IRCT20080831001141N38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080831001141N38.